[go: up one dir, main page]

DD248736A5 - Pharmazeutische zusammensetzungen mit acylierten phospholipiden - Google Patents

Pharmazeutische zusammensetzungen mit acylierten phospholipiden Download PDF

Info

Publication number
DD248736A5
DD248736A5 DD86293707A DD29370786A DD248736A5 DD 248736 A5 DD248736 A5 DD 248736A5 DD 86293707 A DD86293707 A DD 86293707A DD 29370786 A DD29370786 A DD 29370786A DD 248736 A5 DD248736 A5 DD 248736A5
Authority
DD
German Democratic Republic
Prior art keywords
cis
pharmaceutically acceptable
phospholipid
formula
glycero
Prior art date
Application number
DD86293707A
Other languages
German (de)
English (en)
Inventor
Alan J Schroit
Rajiv Nayar
Original Assignee
�����@��������@��@����������@��@��@����������@���������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@��������@��@����������@��@��@����������@���������k�� filed Critical �����@��������@��@����������@��@��@����������@���������k��
Publication of DD248736A5 publication Critical patent/DD248736A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD86293707A 1985-08-19 1986-08-18 Pharmazeutische zusammensetzungen mit acylierten phospholipiden DD248736A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76662585A 1985-08-19 1985-08-19

Publications (1)

Publication Number Publication Date
DD248736A5 true DD248736A5 (de) 1987-08-19

Family

ID=25077017

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86293707A DD248736A5 (de) 1985-08-19 1986-08-18 Pharmazeutische zusammensetzungen mit acylierten phospholipiden

Country Status (18)

Country Link
EP (1) EP0213523B1 (fi)
JP (1) JPS6296431A (fi)
KR (1) KR870001838A (fi)
AT (1) ATE59002T1 (fi)
AU (1) AU591162B2 (fi)
CA (1) CA1273575A (fi)
DD (1) DD248736A5 (fi)
DE (1) DE3676133D1 (fi)
DK (1) DK165314C (fi)
ES (1) ES2001099A6 (fi)
FI (1) FI863311A (fi)
GR (1) GR862144B (fi)
HU (1) HU206045B (fi)
NO (1) NO171886C (fi)
NZ (1) NZ217239A (fi)
PH (1) PH26160A (fi)
PT (1) PT83204B (fi)
ZA (1) ZA866200B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256989A1 (en) * 1986-08-18 1988-02-24 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
DK86988A (da) * 1987-02-25 1988-08-26 Takeda Chemical Industries Ltd Liposompraeparat og anvendelse deraf
WO1991014423A1 (en) * 1990-03-20 1991-10-03 Otsuka Pharmaceutical Co., Ltd. Liposome preparation
DE69429511T2 (de) * 1993-05-21 2002-05-16 The Liposome Co., Inc. Reduzierung von durch liposome induzierte physiologischen gegenreaktionen
JPH10507450A (ja) * 1994-10-14 1998-07-21 ザ リポソーム カンパニー、インコーポレーテッド エーテル脂質リポソームおよびそれらの治療用の使用
US8038984B2 (en) 1998-06-20 2011-10-18 Washington University Membrane-permeant peptide complexes for treatment of sepsis
US7306784B2 (en) 1998-06-20 2007-12-11 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6589503B1 (en) 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US7803351B2 (en) 2004-08-20 2010-09-28 Washington University Blood brain barrier permeation peptides
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP3676296A1 (en) 2017-08-30 2020-07-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-mesothelin radiolabelled single domain antibodies suitable for the imaging and treatment of cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3218027A1 (de) * 1982-05-13 1983-11-17 A. Nattermann & Cie GmbH, 5000 Köln Phospholipidloesungen

Also Published As

Publication number Publication date
NO171886B (no) 1993-02-08
JPS6296431A (ja) 1987-05-02
EP0213523A3 (en) 1987-10-14
AU591162B2 (en) 1989-11-30
NZ217239A (en) 1989-09-27
AU6155686A (en) 1987-02-26
EP0213523A2 (de) 1987-03-11
PH26160A (en) 1992-03-18
PT83204A (en) 1986-09-01
HUT41634A (en) 1987-05-28
DK392786A (da) 1987-02-20
ATE59002T1 (de) 1990-12-15
NO863315D0 (no) 1986-08-18
DK392786D0 (da) 1986-08-18
PT83204B (pt) 1989-03-30
CA1273575A (en) 1990-09-04
FI863311A (fi) 1987-02-20
HU206045B (en) 1992-08-28
FI863311A0 (fi) 1986-08-15
DK165314C (da) 1993-03-29
ES2001099A6 (es) 1988-04-16
ZA866200B (en) 1987-03-25
DK165314B (da) 1992-11-09
KR870001838A (ko) 1987-03-28
EP0213523B1 (de) 1990-12-12
NO863315L (no) 1987-02-20
GR862144B (en) 1986-12-23
DE3676133D1 (de) 1991-01-24
NO171886C (no) 1993-05-19

Similar Documents

Publication Publication Date Title
EP0178624B1 (de) Liposomen aus synthetischen Lipiden
US4863740A (en) Interleukin therapy
JP3074733B2 (ja) 脂肪乳剤
US4983397A (en) Pharmaceutical compositions consisting of acylated phospholipids
EP1581185B1 (de) Liposomale glucocorticoide
AU750481B2 (en) Erythropoietin liposomal dispersion
EP0213523B1 (de) Pharmazeutische Zusammensetzungen mit acylierten Phospholipiden
US4916118A (en) Pharmaceutical administration systems containing chemotactic peptides
EA018246B1 (ru) Везикулярные составы, содержащие производные органических кислот, и процесс их приготовления
DE68919225T2 (de) Zusammensetzung für makrophag-aktivierung.
CH673395A5 (fi)
EP0165123A2 (fr) Dérivés lipophiles de muramylpeptides ayant des propriétés d'activation des macrophages, compositions les contenant et procédé pour les obtenir
CA1309346C (en) Pharmaceutical administration systems containing chemotactic peptides
DE3877365T2 (de) Arzneimittel mit methylcellulose.
CN1213964A (zh) 抗糖皮质激素药物
DE2546001A1 (de) Immunostimulierende phospholipide und sie enthaltende arzneimittel
JPH03106821A (ja) 抗腫瘍剤

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee